If you liked this article you might like

Allergan, Citigroup, Apple: Doug Kass' Views
Allergan, Schlumberger, IBM: Doug Kass' Views
Risking Downgrades; Valuing Banks on Earnings: Jim Cramer's Best Blog
Cramer: Giving in to Trump Risks Downgrades by Analysts